Oncad for DynaCAD is an FDA-cleared, fully automated morphological system for the detection and analysis by a radiologist of suspicious breast lesions. It uses a patented mathematical algorithm to analyze the entire breast and draw a physician’s attention to abnormal morphology during a contrast-enhanced breast MRI. This approach also delineates the extent of the disease by measuring margin sharpness to determine the degree of lesion vascularization. The suspicious lesions are marked with a color overlay, light pink for moderate suspicion and dark pink for highly suspicious lesions.

For more information: www.invivocorp.com

Related Content

News | Women's Health

October 20, 2021 — In conjunction with ongoing Breast Cancer Awareness Month efforts, Hologic, Inc., an innovative ...

Time October 20, 2021
arrow
News | Mammography

October 19, 2021 — If Black women begin mammography screening every other year starting at age 40, breast cancer deaths ...

Time October 19, 2021
arrow
News | Women's Health

October 8, 2021 — An analysis of nearly 200,000 patients who received mammograms between 2006 and 2015 across three U.S ...

Time October 08, 2021
arrow
News | Radiation Therapy

October 7, 2021 — ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent ...

Time October 07, 2021
arrow
Feature | Cardiac Imaging

October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade ...

Time October 06, 2021
arrow
News | Women's Health
October 4, 2021 — Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health ...
Time October 04, 2021
arrow
News | Breast Imaging
October 4, 2021 — A non-invasive, patient-friendly imaging technique can help physicians make treatment decisions for ...
Time October 04, 2021
arrow
News | Breast Imaging

September 28, 2021 — A computer program trained to see patterns among thousands of breast ultrasound images can aid ...

Time September 28, 2021
arrow
News | Radiology Business

September 27, 2021 — Esaote, an Italian company leader in the biomedical equipment sector – ultrasound, MRI and software ...

Time September 27, 2021
arrow
News | Cardiac Imaging

September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by ...

Time September 23, 2021
arrow
Subscribe Now